Bassoon proteinopathy drives neurodegeneration in multiple sclerosis

2019 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Bassoon proteinopathy drives neurodegeneration in multiple sclerosis​
Schattling, B.; Engler, J. B.; Volkmann, C.; Rothammer, N.; Woo, M. S.; Petersen, M. & Winkler, I. et al.​ (2019) 
Nature Neuroscience22(6) pp. 887​-896​.​ DOI: https://doi.org/10.1038/s41593-019-0385-4 

Documents & Media

License

GRO License GRO License

Details

Authors
Schattling, Benjamin; Engler, Jan Broder; Volkmann, Constantin; Rothammer, Nicola; Woo, Marcel S.; Petersen, Meike; Winkler, Iris; Kaufmann, Max; Rosenkranz, Sina C.; Fejtova, Anna; Thomas, Ulrich; Bose, Aparajita; Bauer, Simone; Träger, Simone; Miller, Katharine K.; Brück, Wolfgang ; Duncan, Kent E.; Salinas, Gabriela ; Soba, Peter; Gundelfinger, Eckart D.; Merkler, Doron ; Friese, Manuel A.
Abstract
Multiple sclerosis (MS) is characterized by inflammatory insults that drive neuroaxonal injury. However, knowledge about neuron-intrinsic responses to inflammation is limited. By leveraging neuron-specific messenger RNA profiling, we found that neuroinflammation leads to induction and toxic accumulation of the synaptic protein bassoon (Bsn) in the neuronal somata of mice and patients with MS. Neuronal overexpression of Bsn in flies resulted in reduction of lifespan, while genetic disruption of Bsn protected mice from inflammation-induced neuroaxonal injury. Notably, pharmacological proteasome activation boosted the clearance of accumulated Bsn and enhanced neuronal survival. Our study demonstrates that neuroinflammation initiates toxic protein accumulation in neuronal somata and advocates proteasome activation as a potential remedy.
Issue Date
2019
Journal
Nature Neuroscience 
ISSN
1097-6256; 1546-1726
eISSN
1546-1726
Language
English

Reference

Citations


Social Media